| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.056 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |